Approvals/TGA/SEROFLO MULTIHALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler

Approved

STANDARD

SEROFLO MULTIHALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e64c33e57b4cc0b7
Product Name: SEROFLO MULTIHALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler
Artg Id: 331316
Artg Name: SEROFLO MULTIHALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2021-08-12
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e64c33e57b4cc0b7

Type

Standard